• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Maria G. Montez, RN, MSHP

Latest:

Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants

Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.



Norman LaFrance, MD

Latest:

Cost of Care for Malignant and Benign Renal Masses

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.



Mark E. Lewis, MPH

Latest:

ACO Use of Case Mix Index to Comprehensively Evaluate Postacute Care Partners

This article describes how one accountable care organization (ACO) created a risk-adjusted algorithm to evaluate current and potential candidates for skilled nursing facility partnerships.


Michael A. Rodriguez, MD, MPH

Latest:

Cervical Cancer Screening Overuse and Underuse: Patient and Physician Factors

Cervical cancer screening underuse and overuse occur commonly in clinical practice and identifiable patient and physician factors can be targeted for quality improvement.



Qianyi Li, MS

Latest:

Cost-effectiveness of Intensification With SGLT2 Inhibitors for Type 2 Diabetes

Adding a sodium-glucose co-transporter 2 (SGLT2) inhibitor dominated switching to a glucagon-like peptide 1 receptor agonist over the lifetimes of patients with type 2 diabetes not at glycated hemoglobin A1c target after treatment with metformin plus a dipeptidyl peptidase-4 inhibitor.






Jennifer Klima, PhD

Latest:

A Deep Learning Model for Pediatric Patient Risk Stratification

Artificial intelligence based on medical claims data outperforms traditional models in stratifying patient risk.


Neehar D. Parikh, MD, MS

Latest:

Humanistic and Economic Burden of Hepatocellular Carcinoma: Systematic Literature Review

Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.


Pei Tang, MS, MA

Latest:

Diabetes Disease Management in Medicare Advantage Reduces Hospitalizations and Costs

A disease management program for Medicare Advantage patients with diabetes and coronary artery disease resulted in significantly reduced hospital admissions and total healthcare costs.


Christine McDonough, PhD

Latest:

Health Insurance Design and Conservative Therapy for Low Back Pain

This study examined the association between health insurance design features and choice of physical therapy or chiropractic care by patients with new-onset low back pain.


Roger Luo, PhD

Latest:

Impact of Compliance With Proton Pump Inhibitors on NSAID Treatment

Patients with gastroesophageal reflux disease who are compliant with proton pump inhibitor therapy stay on NSAIDs longer than noncompliant patients.


Benjamin Kligler, MD, MPH

Latest:

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.




Gregory P. Hess, MD, MBA, MSc

Latest:

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.


Carroline Lobo, MS

Latest:

Medicaid Prior Authorization and Opioid Medication Abuse and Overdose

Enrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.





O. Kenrik Duru, MD, MSHS

Latest:

Optimizing Enrollment in Employer Health Programs: A Comparison of Enrollment Strategies in the Diabetes Health Plan

An automatic enrollment strategy for health insurance programs may not only increase the total number of enrollees but may also decrease some enrollment disparities.



Aparajita Zutshi, PhD

Latest:

Early Evaluations of the Medical Home: Building on a Promising Start

Findings from a systematic evidence review of the medical home are promising, but indicate the critical need for stronger evaluations to guide policy makers.



Ted E. Palen, PhD, MD, MPSH

Latest:

Computerized Alert Reduced D-Dimer Testing in the Elderly

A targeted computerized alert at the time of physician order entry reduced the use of D-dimer testing among patients 65 years and older.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.